Preliminary analysis of cerebrospinal fluid proteome in patients with neurocysticercosis

Chinese Medical Journal

Volumn 122, Issue 9, 2009, Pages 1003-1008

  Tian, Xiao Jun ^a   Li, Jing Yi ^a   Huang, Yong ^b   Xue, Yan Ping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Shandong Institute of Parasitic Diseases   (China)

Author keywords

Cerebrospinal fluid; Neurocysticercosis; Proteomic analysis; Two dimensional difference in gel electrophoresis

Indexed keywords

ADENOSINE TRIPHOSPHATE; LIPOCALIN; PROSTAGLANDIN D SYNTHASE; TRANSFERRIN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; IRON METABOLISM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROCYSTICERCOSIS; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

CEREBROSPINAL FLUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEUROCYSTICERCOSIS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 68149157428     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.09.001     Document Type: Article

References (21)

1. Willingham AL 3rd, Engels D. Control of Taenia solium cysticercosis/taeniosis. Adv Parasitol 2006; 61: 509-566.
2. Kraft R. Cysticercosis: an emerging parasitic disease. Am Fam Physician 2007; 76: 91-96.
3. Lee JW, Namkoong H, Kim HK. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease. BMC Neurol 2007; 7: 14.
4. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, et al. Identification of potential CSF biomarkers in ALS. Neurology 2006; 66: 1218-1222.
5. Yang YR, Liu SL, Qin ZY, Liu FJ, Qin YJ, Bai SM, et al. Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome. Cell Mol Neurobiol 2008; 28: 737-744.
6. Choe LH, Dutt MJ, Relkin N, Lee KH. Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease. Electrophoresis 2002; 23: 2247-2251.
7. Davidsson P, Sjogren M, Andreasen N, Lindbjer M, Nilsson CL, Westman-Brinkmalm A. Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. Brain Res Mol Brain Res 2002; 109: 128-133.
8. Vihinen M. Bioinformatics in proteomics. Biomol Eng 2001; 18: 241-248.
9. Karp NA, Kreil DP, Lilley KS. Determining a significant change in protein expression with DeCyderTM during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics 2004; 4: 1421-1432.
10. Alban A, David SO, Bjordesten L. A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003; 3: 36-44.
11. Gomme PT, McCann KB, Bertolini J. Transferrin: structure, function and potential therapeutic actions. Drug Discov Today 2005; 10: 267-273.
12. Qian ZM, Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev 1998; 27: 257-267.
13. Lehmensiek V, Sussmuth SD, Brettschneider J, Tauscher G, Felk S, Gillardon F, et al. Proteome analysis of cerebrospinal fluid in Guillain-Barré (GBS). J Neuroimmunol 2007; 185: 190-194.
14. Roos-Mattjus P, Sistonen L. The ubiquitin-proteasome pathway. Ann Med 2004; 36: 285-295.
15. Wang J, Maldonado MA. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol 2006; 3: 255-261.
16. Shah IM, Di Napoli M. The ubiquitin-proteasome system and proteasome inhibitors in central nervous system diseases. Cardiovasc Hematol Disord Drug Targets 2007; 7: 250-273.
17. Klimaschewski L. Ubiquitin-dependent proteolysis in neurons. News Physiol Sci 2003; 18: 29-33.
18. Urade Y, Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm 2000; 58: 89-120.
19. Kagitani-Shimono K, Mohri I, Oda H, Ozono K, Suzuki K, Urade Y, et al. Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis. Neuropathol Appl Neurobiol 2006; 32: 64-73.
20. Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 2000; 1482: 298-307.
21. Tumani H, Nau R, Felgenhauer K. Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 1998; 44: 882-889.